{"created_at":"Tue Feb 03 20:46:21 +0000 2015","id":562713726034640898,"id_str":"562713726034640898","text":"Sanofi\u2019s Chosen Ones: Regeneron\u2019s Alirocumab Developments and MannKind\u2019s Afrezza Launch https:\/\/t.co\/hHkhT54ibv $SNY $REGN $MNKD","source":"\u003ca href=\"http:\/\/twitter.com\" rel=\"nofollow\"\u003eTwitter Web Client\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":2350639447,"id_str":"2350639447","name":"Hung Tran, MS, MD","screen_name":"DoctorTranRI360","location":"Charlotte, NC","url":"https:\/\/www.retailinvestor360.com","description":"To Inform. To Educate. To Empower. Tweets are not recommendations to buy\/sell any security. We're not RIA & are NOT interested in purchasing twitter followers.","protected":false,"verified":false,"followers_count":3088,"friends_count":3186,"listed_count":30,"favourites_count":2258,"statuses_count":7881,"created_at":"Tue Feb 18 20:27:18 +0000 2014","utc_offset":null,"time_zone":null,"geo_enabled":true,"lang":"en","contributors_enabled":false,"is_translator":false,"profile_background_color":"FFDD00","profile_background_image_url":"http:\/\/pbs.twimg.com\/profile_background_images\/477213574708736001\/UXVra-ti.jpeg","profile_background_image_url_https":"https:\/\/pbs.twimg.com\/profile_background_images\/477213574708736001\/UXVra-ti.jpeg","profile_background_tile":true,"profile_link_color":"009DFF","profile_sidebar_border_color":"000000","profile_sidebar_fill_color":"252429","profile_text_color":"666666","profile_use_background_image":true,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/556659372135170048\/75Du3W7m_normal.png","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/556659372135170048\/75Du3W7m_normal.png","profile_banner_url":"https:\/\/pbs.twimg.com\/profile_banners\/2350639447\/1415924411","default_profile":false,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweet_count":0,"favorite_count":0,"entities":{"hashtags":[],"trends":[],"urls":[{"url":"https:\/\/t.co\/hHkhT54ibv","expanded_url":"https:\/\/www.retailinvestor360.com\/biotech\/764-sanofi-s-chosen-ones-regeneron-s-alirocumab-developments-and-mannkind-s-afrezza-launch.html#.VNEzjiDjY88.twitter","display_url":"retailinvestor360.com\/biotech\/764-sa\u2026","indices":[88,111]}],"user_mentions":[],"symbols":[{"text":"SNY","indices":[112,116]},{"text":"REGN","indices":[117,122]},{"text":"MNKD","indices":[123,128]}]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"low","lang":"en","timestamp_ms":"1422996381659"}
